Regeneron Pharmaceuticals, Inc.
μκ°μ΄μ‘
$68.6B
κΈλ‘λ² μμ
#236
μλ μ΅κ³ μΉ
$89.7B
2023-12-31
μ΄ μ±μ₯λ₯
+0%
2026λ μ΄ν
Regeneron Pharmaceuticals, Inc. μκ°
Regeneron Pharmaceuticals, Inc. (REGN) is a United States-based company in the Biotechnology industry, part of the Healthcare sector. With a current market capitalization of $68.6B, it is ranked #236 among the world's largest companies. Its market cap peaked at $89.7B and reached as high as rank #126 in 2023.
Regeneron Pharmaceuticals, Inc. μκ°μ΄μ‘ μΆμ΄ (2026β2026)
Regeneron Pharmaceuticals, Inc. λΉκ΅
μμ μΆμ΄
| μ°λ | μκ°μ΄μ‘ | μμ | μ λ λλΉ λ³ν |
|---|---|---|---|
| 2026 | $68.6B | #236(β56) | -13.5% |
| 2025 | $79.3B | #180(β8) | +9.0% |
| 2024 | $72.8B | #172(β46) | -18.9% |
| 2023 | $89.7B | #126(β3) | +21.7% |
| 2022 | $73.7B | #123(β27) | +14.2% |
| 2021 | $64.5B | #150(β24) | +30.7% |
| 2020 | $49.4B | #174(β11) | +28.7% |
| 2019 | $38.4B | #185(β45) | +0.5% |
| 2018 | $38.2B | #140(β9) | -0.7% |
| 2017 | $38.4B | #149(β24) | +2.4% |
| 2016 | $37.5B | #125(β58) | -32.4% |
| 2015 | $55.5B | #67(β23) | +32.3% |
| 2014 | $41.9B | #90(β35) | +49.1% |
| 2013 | $28.1B | #125(β20) | +60.9% |
| 2012 | $17.5B | #145(β94) | +208.6% |
| 2011 | $5.7B | #239(β27) | +68.8% |
| 2010 | $3.4B | #266(β2) | +35.8% |
| 2009 | $2.5B | #264(β8) | +31.7% |
| 2008 | $1.9B | #256(β6) | -24.0% |
| 2007 | $2.5B | #262(β6) | +20.3% |
| 2006 | $2.1B | #256 | +26.2% |
| 2005 | $1.6B | #256(β4) | +72.6% |
| 2004 | $941.1M | #252(β15) | -37.4% |
| 2003 | $1.5B | #237(β27) | -20.5% |
| 2002 | $1.9B | #210(β12) | -34.3% |
| 2001 | $2.9B | #198(β25) | -20.1% |
| 2000 | $3.6B | #173 | +176.6% |
| 1999 | $1.3B | #173 | +72.9% |
| 1998 | $753.6M | #173(β10) | -13.9% |
| 1997 | $874.9M | #163(β37) | -46.9% |
| 1996 | $1.6B | #126(β6) | +26.5% |
| 1995 | $1.3B | #120(β13) | +325.0% |
| 1994 | $306.5M | #133 |
κΈ°ν ν¬μ€μΌμ΄ κΈ°μ
μμ£Ό 묻λ μ§λ¬Έ
What is Regeneron Pharmaceuticals, Inc.'s market cap?
Regeneron Pharmaceuticals, Inc. (REGN) has a market capitalization of $68.6B, making it the #236 largest company in the world by market cap.
What was Regeneron Pharmaceuticals, Inc.'s highest market cap?
Regeneron Pharmaceuticals, Inc.'s all-time high market cap was $89.7B, reached in 2023-12-31. Its highest rank was #126 in 2023.
What sector is Regeneron Pharmaceuticals, Inc. in?
Regeneron Pharmaceuticals, Inc. is in the Healthcare sector, specifically the Biotechnology industry. It is based in United States.
How has Regeneron Pharmaceuticals, Inc.'s market cap changed over time?
Regeneron Pharmaceuticals, Inc. has been tracked since 2026. Its market cap has grown by 0% from $68.6B in 2026 to $68.6B today.